Patent · US Active

Substituted heterocyclic ethers and their use in CNS disorders

US8026257B2 · kind B2 · utility

4Cited by

2References

17Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Andrew P. Degnan · New Haven, US
George O. Tora · Langhorne, US
Derek Denhart · Wallingford, US
Vivekananda M. Vrudhula · Killingworth, US
John E. Macor · Guilford, US
Joanne J. Bronson · Madison, US

Key dates

Filing date	Jul 1, 2008
Grant date	Sep 27, 2011
Priority date	—
Expiry date	Jun 18, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.